Back to Endocrinology
Endocrinologyv2014Evidence-Based

Myxedema Coma Diagnostic Score

Diagnostic scoring system for myxedema coma (MC), a rare but life-threatening decompensated state of extreme hypothyroidism. This validated scoring system facilitates early recognition and treatment by evaluating thermoregulatory, central nervous, cardiovascular, gastrointestinal, and metabolic dysfunction along with precipitating events.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
myxedema coma score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Myxedema Coma Diagnostic Score is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within endocrinology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Myxedema Coma Score = Body Temperature Points + Central Nervous System Points + Cardiovascular Points + Gastrointestinal Points + Metabolic Points + Precipitating Event Points

Clinical Pearls & Practice Notes

  • Myxedema coma is a rare but life-threatening decompensated state of extreme hypothyroidism with mortality rates of 25-50%
  • The scoring system has 100% sensitivity and 85.71% specificity at a cutoff score of 60
  • Area under the ROC curve is 0.88 (95% CI: 0.65 to 1.00), indicating excellent diagnostic performance
  • Score ≥60 is potentially diagnostic for myxedema coma and requires immediate treatment
  • Scores 45-59 classify patients at risk and warrant urgent thyroid function testing
  • Score <25 makes myxedema coma unlikely, though severe hypothyroidism may still be present
  • Common precipitating events include infection, surgery, trauma, medications (sedatives, narcotics), cold exposure
  • Temperature measurement should be core temperature; skin temperature may be misleadingly normal
  • Early recognition and treatment are critical as delayed treatment significantly increases mortality
  • Treatment includes IV levothyroxine, supportive care, and management of precipitating factors
  • The scoring system should be used in conjunction with clinical judgment and thyroid function tests

Evidence & Literature Citations

  1. Popoveniuc G, Chandra T, Sud A, Sharma M, Blackman MR, Burman KD, et al. A diagnostic scoring system for myxedema coma. Endocr Pract. 2014;20(8):808-17. doi: 10.4158/EP13460.OR.
  2. Mathew V, Misgar RA, Ghosh S, Mukhopadhyay P, Roychowdhury P, Pandit K, et al. Myxedema coma: a new look into an old crisis. J Thyroid Res. 2011;2011:493462. doi: 10.4061/2011/493462.
  3. Wall CR. Myxedema coma: diagnosis and treatment. Am Fam Physician. 2000;62(11):2485-90.

Score Interpretation Ranges

Unlikely0 – 24 pts

Myxedema coma unlikely

Possible25 – 44 pts

Myxedema coma possible but unlikely

At Risk45 – 59 pts

Patient at risk for myxedema coma

Diagnostic60 – 100 pts

Highly suggestive of myxedema coma

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.